Navigation Links
Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
Date:1/24/2008

LAWRENCEVILLE, N.J., Jan. 24 /PRNewswire/ -- Aton Pharma, Inc., a global specialty pharmaceutical company, announced today that it has launched an expanded, comprehensive distribution program that incorporates sampling, reimbursement assistance and patient education resources, for the dry eye medication Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert). Lacrisert is a unique preservative-free, once-daily*, sustained release prescription insert that helps to retain moisture, stabilize the tear film, and lubricate the eye.

"As part of Aton's mission to ensure patient access to important therapies, we have established supply chain and commercialization processes to make certain Lacrisert is well-supported and readily available to patients," said Michael G. Wells, Chief Executive Officer of Aton Pharma. "As a company specializing in essential treatments for under-treated diseases, we are proud to provide a therapeutic option for dry eye with a strong history of effectiveness and safety."

"Once the patient inserts Lacrisert in the morning, it usually lasts the entire day, so it's something that is helpful to offer patients suffering from chronic pain from dry eye disease," explained Penny Asbell, M.D., Professor of Ophthalmology at The Mount Sinai School of Medicine and co-author of the pivotal textbook 'Dry Eye Disease, the Clinician's Guide to Diagnosis and Treatment.' "One of the advantages of Lacrisert is that it is preservative- free."

Lacrisert is administered into the inferior cul-de-sac of the eye, where it gently dissolves to provide lubrication and protection to the surface of the eye. In some patients, Lacrisert may also help slow, stop or reverse further damage to the corneal surface.

"Due to the great variety among dry eye patient profiles, practitioners need to be armed with as many effective treatment options as possible," added Dr. Asbell. "Our challenge is to match the patients with the right medications to give
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
2. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
3. Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists
4. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
5. Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits
6. Pharmaxis Aridol Gains First Asian Approval
7. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
11. Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...   ISN has released its third annual ... publication series. With data aggregated from over eight ... within its online contractor management platform, ISNetworld, this three-part ... (KPI) statistics. The Contractor ... is available in two industry specific volumes: Oil ...
(Date:12/17/2014)... 16, 2014 “Never say, ‘I ... Universität Marburg’s Department of Physics, advises young women ... newly released SPIE Women in Optics 18-month ... shy to ask questions.” , In the annual ... mathematics) occupations ranging from university professor and laboratory ...
(Date:12/17/2014)... December 17, 2014 This report ... Quartz Tubing industry. For an overview analysis, the ... application, industry chain structure, industry overview, policy analysis, ... tubing industry has witnessed rapid development with ... of acquisitions. This report mentions quartz tubing upstream ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
Breaking Biology Technology:ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 2ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 3Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 32020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
... in ... 2008 -, ... the year ended December,31, 2007, and highlighted the corporate milestones achieved during ... the Company achieved the following corporate milestones:, Progress on Lead Candidate ...
... SAN DIEGO, March 13 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ... overview of the company, including its clinical development and,discovery programs, ... Annual Health Care Conference Presentation: Wednesday, ... a.m. Pacific Time) at the Boston Marriott ...
... Surgical Recoveries, FREDERICK, Md., March 13 ... Breast Recovery Kit,for the relief of edema and ... Eppley, MD, DMD, the 1 Day Breast Recovery ... active lives the day,after surgery. Using the patented ...
Cached Biology Technology:Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results 2Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results 3Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results 4Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results 5Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results 6Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results 7Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 3BioElectronics Launches '1 Day Breast Augmentation Recovery Kit' 2
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... Five years ago, Professor Mirko Gojic, a researcher at the ... of researchers could do to lower the price of ,smart ... original cold-forged shape, returning the pre-deformed shape by heating ... industries. The idea was there, but problems quickly aroused from ...
... design of vaccines is rapidly expanding their use, safety, and ... of OMICS sciences for global health and vaccine design is ... special issue of OMICS: A Journal of Integrative Biology ... Inc . The issue is available free online . ...
... Sept. 23, 2011 Two Arizona university graduate students ... each received $50,000 grants from the Salt River Project ... TGen,s Pathogen Genomics Division in Flagstaff, and Brooke Hjelm, ... are each the recipients of $50,000 awards from SRP,s ...
Cached Biology News:Shape memory materials ready for mass production 2Shape memory materials ready for mass production 321st century vaccines -- innovation in design and rational use 221st century vaccines -- innovation in design and rational use 3TGen graduate students receive $50,000 each from Salt River Project's support program 2
Certified U.S. origin. Bovine Serum:, *Certified U.S. origin. Available raw, nonsterile filtered, or sterile filtered. , , *Sterility tested , , *Low Hemoglobin levels , , *Mycoplasma testing upon...
...
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: